0.00 (0.00)
Prev Close 0.04
Open 0.04
Day Low/High 0.04 / 0.04
52 Wk Low/High 0.01 / 0.09
Volume 1.00K
Exchange OTC
Shares Outstanding 10.56B
Market Cap 422.40K
Div & Yield N.A. (N.A)

RBCC Gains New Funding Injection, Readies Aggressive Expansion Plan

Rainbow Coral Corp. (OTCQB: RBCC) has received key new financing which will help propel the company's aggressive growth plans in battling opioid and alcohol addiction, personalized medicine and 3D bioprinting.

RBCC Encourages Obama To Rethink Opioid Restriction, Seek More Complete Addiction Solution

Rainbow Coral Corp. (OTCQB: RBCC) believes U.

RBCC: New Breakthroughs Add To Personalized Medicine's Growing Power And Appeal

Scientists and researchers continue to make astounding advances in personalized medicine, developments that Rainbow Coral Corp.

RBCC Hails NYC Mayor's Bid To End The Big Apple's Opioid Addiction, Offers Assistance

Rainbow Coral Corp. (OTCQB: RBCC) wants New York Mayor Bill De Blasio and his wife, Chirlane McCray, to know it's ready with an ample supply of Naltrexone to help their efforts to eradicate opioid addiction in America's...

RBCC: Drug Approvals Show Personalized Medicine Gaining Favor With Feds And Public

Rainbow Coral Corp. (OTCQB: RBCC) expects personalized medicine to grow even faster after examining the Federal Drug Administration's (FDA) list of drug approvals in 2015 - a list that includes a high percentage of...

RBCC: Survey Shows Teen Substance Abuse Falling, But Much Work Remains

Rainbow Coral Corp. (OTCQB: RBCC) is hailing a recent nationwide survey that shows substance abuse and addiction among American teens has dropped, but the company says a lot of hard work still lies ahead before the current...

Dynamics Driving Stunning Growth Of Personalized Medicine Bode Well For RBCC

A prominent doctor and healthcare expert says three key factors will drive continued future growth in personalized medicine and these elements spell opportunity for Rainbow Coral Corp.

RBCC: Report Shows Personalized Medicine Market To More Than Double By 2022

Rainbow Coral Corp. (OTCQB: RBCC) continues focusing on the personalized medicine market and expects its efforts to increase now that a prominent research study indicates the segment will grow to a nearly $2.

RBCC Aims To Increase Focus On Real 'Gateway Drug' Plaguing North America

Rainbow Coral Corp. (OTCQB: RBCC) believes lawmakers and politicians have lost sight of a drug that far too often leads users to abuse and addiction, and unlike substances candidates and activists rail against, this one is...

RBCC Makes Great Strides In 2015, Looks Ahead To Eventful New Year

Rainbow Coral Corp. (OTCQB: RBCC) President and CEO Kimberly Palmer issued the following open letter to stockholders today, reviewing the Company's 2015 achievements and providing a peek at what's to come in 2016: ...

RBCC: Need Grows For Affordable Treatment As Opioid Overdose Deaths Outpace Heroin

Rainbow Coral Corp. (OTCQB: RBCC) intends to make 2016 a year where a sizable dent is finally made in the ongoing crisis concerning the alarming rate of opioid overdose deaths in the U.

RBCC Exploring Options And Partners For Alcohol Addiction Treatment Center In Texas

Rainbow Coral Corp. (OTCQB: RBCC) is investigating the feasibility of starting a low-cost alcohol addiction treatment center in Texas, part of the company's previously announced strategy of creating an inclusive,...

RBCC To Target Massive New Venture Capital Pouring Into American Healthcare

A record amount of venture capital is flowing into the U.S.

RBCC Moves To Close Key Addiction Services Deals, Wraps Up Year Of Great Progress

As Rainbow Coral Corp. (OTCQB: RBCC) works diligently on several important agreements in opioid addiction and treatment sectors, the company is also looking back on a calendar 2015 full of substantial achievements.

RBCC Offers Solutions To Growing Opioid Addiction Crisis That Kills 44 People Per Day

Rainbow Coral Corp. (OTCQB: RBCC) is heeding an urgent call to action put out by a prominent group of medical scientists looking to end the nation's expanding prescription opioid addiction epidemic - a problem that is now...

RBCC Excited About Rapid Advances In Bioprinting

Rainbow Coral Corp. (OTCQB: RBCC) and partner  Nano3D Biosciences (n3D) are pondering potential future moves as researchers make tremendous strides in the field of bioprinting, meaning it may soon be...

RBCC Maps Out Strategy To Curb Addiction In Canada's Indigenous Communities

Rainbow Coral Corp. (OTCBB: RBCC) has begun working on a way to increase use of the anti-addiction drug Naltrexone as well as to expand access to treatment in Canada's First Nations, Inuit and Métis indigenous...

RBCC Working To Ensure Opioid Addicts Can Get Treatment Following Surprising Study

Rainbow Coral Corp. (OTCBB: RBCC) has promised to double its efforts to make certain people addicted to opioids have access to treatment after a major university study showed nearly 80 percent are shut out of the...

RBCC Partner N3D's Latest Article Shows Magnetic Bioprinting's Versatility And Promise

Rainbow Coral Corp. (OTCBB: RBCC) partner n3D has gotten a key article published on a recognized medical technology company's website, giving n3D and its considerable bioprinting expertise greater marketplace recognition...

RBCC Ally N3D Inks Major Global Partnership Deal For Bioprinting Technology

Rainbow Coral Corp. (OTCBB: RBCC) partner  Nano3D Biosciences (n3D) has signed a major worldwide agreement with leading biotech supplier Greiner Bio-One, continuing the innovative company's steady...

RBCC's Inclusionary Addiction Therapy Pricing Offers Hope To Those Shut Out From Help

Rainbow Coral Corp. (OTCBB: RBCC) has won praise for its recent announcement that it will begin competitively pricing its addiction therapy programs, setting a new standard in affordability.

RBCC: Talks With Potential Canadian Joint Venture Partners Exceed Expectations

Rainbow Coral Corp. (OTCBB: RBCC) reports recent talks with possible joint venture partners were quite productive and the company has high hopes it can work out agreements with several prospects as it nears its much...

RBCC To Make Addiction Therapy Affordable For Everyone

Rainbow Coral Corp. (OTCBB: RBCC) will now competitively price its groundbreaking addiction treatment services to lead the way in affordability.

RBCC Actively Seeking Joint Venture Partners For Upcoming Canadian Rollouts

Rainbow Coral Corp. (OTCBB: RBCC) has been aggressively pursuing potential partners for joint venture opportunities related to the company's proposed Canadian personalized medicine and addiction treatment rollouts.

RBCC: World's Largest Stem Cell Collection Could Lead To New Medical Advances

California has opened a new human stem cell collection that officials say will enable new disease investigations and could result in exciting drug discoveries.

RBCC Partner N3D's Innovative Toxicity Test Highlighted In Major Scientific Journal

Rainbow Coral Corp. (OTCBB: RBCC) partner n3D has just had an important manuscript about 3D bioprinting and cell culture screenings published in the journal Scientific Reports, a Nature publication.

RBCC: Federal Initiative Could Further Boost Personalized Medicine In U.S.

Rainbow Coral Corp. (OTCBB: RBCC) is weighing options and considering future moves now that the Obama Administration has begun soliciting the medical community and the public for ideas on personalizing medical...

RBCC: New Jersey Initiates New Law Boosting Medication Assisted Treatment

Rainbow Coral Corp. (OTCBB: RBCC) expects legislation in New Jersey giving additional credence and importance to Medication Assisted Treatment (MAT) programs to have a positive effect on patients and on distribution of...

RBCC Offers Solution To Canada's Growing Opioid Abuse Crisis

With more and more Canadians becoming hooked on prescription opioids, the federal government in Ottawa has started to consider limits and prescription monitoring programs to curb the growing abuse.

RBCC Partner N3D Signs Research Sponsorship Agreement With Prominent Medical School

Rainbow Coral Corp. (OTCBB: RBCC) partner Nano3D Biosciences (n3D) has just inked an important sponsored research agreement with the prestigious University of Texas Health Science Center at Houston (UTHealth)...